RSS

CE

MedMira — which develops rapid diagnostic technology platforms and testing solutions — has received the CE Mark for its syphilis/HIV rapid test, Multiplo TP/HIV. more

Technology

Novartis drug Odomzo gains approval for locally advanced basal cell carcinoma, providing non-invasive therapy for patients more

News